Callan Family Office, LLC United Therapeutics Corp Transaction History
Callan Family Office, LLC
- $1.57 Trillion
- Q4 2024
A detailed history of Callan Family Office, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Callan Family Office, LLC holds 918 shares of UTHR stock, worth $340,339. This represents 0.02% of its overall portfolio holdings.
Number of Shares
918Holding current value
$340,339% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding UTHR
# of Institutions
702Shares Held
60.7MCall Options Held
194KPut Options Held
292K-
Wealthfront Advisers LLC18.3MShares$6.79 Billion5.38% of portfolio
-
Black Rock Inc. New York, NY5.47MShares$2.03 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$1.65 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$1.06 Billion15.42% of portfolio
-
Wellington Management Group LLP Boston, MA2.46MShares$913 Million0.16% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $16.9B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...